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Purpose- Successful use of the distal adjunctive arteriovenous fistula (dAVF) for the 
enhancement ofprosthetic graft patency rates in the crural position is critically dependent 
on the qualitative and quantitative aspects of the arterial and venous runoff. Precise 
technical performance of the fismla is equally vital to secure optimal results. The purpose 
ofthis study was to determine current prosthetic graft patency and limb salvage rates using 
a modified version of the common ostium dAVF. 
Methods: The standard method to create the common ostittrn variant of dAVF has been 
mogfied to improve apposition of the "otomy" sites of the artery and rein, avoid twisting 
and stenosis by terminating the fisuala suture line at the artery-vein junctures, reshaping 
the ovoid ostium to a rectangular shape, and finally, use of multiple interrupted heel-toe 
sntures .  
Results: Since 1979 we have created 290 fistulas in 281 patients who required leg 
revascularization procedures. In different ime periods we have documented improving 
graft patency and limb salvage rates. Fistula patency, reflected by annual attrition rates of 
13% to 26% per year, continues as a challenge for long-term results. Current 3-year 
s econdary cumulative graft patency and limb salvage rates by life table analysis are 61% and 
74%, respectively. The conduit material may play a role with regard to steal phenomena and 
the need for banding techniques. 
Conclusion: Configuration of the adjunctive dAVF may impact on prosthetie graft patency 
in the crural position. In addition, the type of graft material used for bypass may be 
instrumental in preventing or precipitating the steal phenomenon. These issues require 
further study to better understand flow dynamics, patterns of intimal hyperplasia, nd 
blood distribution as a function of conduit material and impedance of the arterial and 
venons runoff. (J Vasc Surg 1996;24:240-8.) 
Over the past decade there has been a slow but 
sure increase in the number of studies that deal with 
the creafion ofdistal arteriovenous fi tulas (dAVF) to 
maintain prosthetic graft patency in leg revasculariza- 
Uon. To attain optimal results, variauons of fistula 
location and configuration have been devised. 1-4 The 
advocates of these various patterns offistula construc- 
tion have all shown enhanced patency and limb 
From the Department of Surgery, Section of Vascular Surgery, 
Englewood Hospital and Medical Center. 
Reprint requests: Herbert Dardik, MD, 350 Engle Street, Engle- 
wood, NJ 07631. 
Copyright © 1996 by The Society for Vascular Surgeryand 
International Society for Cardiovascular Surgery, North Ameri- 
can Chapter. 
0741-5214/96/$5.00 +  24/1/72331 
240 
salvage rates, although prospective randomized stud- 
ies have to date not been performed. Out group has 
had extensive xperience with the common ostium 
method, and this experience has resulted in a series of 
technical modifications that have had a positive im- 
pact on early graft patency and limb salvage rates. The 
impact on mid-and long-term patency rates requires 
further analysis in comparison with other configura- 
tions. 
MATERIALS AND METHODS 
From November 1979 to May 1995, 290 dAVFs 
were used as adjuncts to revascularization procedures 
in the leg in 281 patients. Although five dAVF 
configurations were used, the overwhelming type was 
the common ostium type (n=280;  Fig. 1). The 
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Fig. 1. Configurations of various dAVFs: A, common ostium (n = 280); B, proximal vein 
piggyback (n = 3); C, distal vein piggyback (n = 1); D, Vein interposition (VI) (n = 2); 
E, Rernote side-to-side (n = 4); F, Proximal side-to-side (not used in this series). 
operative procedures are shown m Table I and in- 
cluded 275 bypasses with prosthetics, 11 bypasses 
with autologous vein, 3 composite bypasses, and 1 
bypass pcrformed after proximal native vessel throm- 
bectomy. 
Demographic nformation for this series (1990 to 
1995) showed no differences between the tibial and 
peroneal groups. The mean age was 68 years, with a 
range of 37 to 83 years. Gender distribution favored 
men by more than 2:1. More than half of the patients 
were diabetic (62%), smoked (52%), and had had 
previous attempts made at revascularization f the 
involved limb (52%). Not includcd in this series are six 
dAVF procedures that were performed at inframalle- 
olar levels with single-vein or double-vein fistula 
constructions. Uniform failure within 6 months was 
the rule for this subgroup with a single exception. 
A deseription of the dAVF common ostium tech- 
nique was provided in our first series review in 1983.1 
Since then we have modified our technique several 
times, most recently in 1993. The details are summa- 
rized: 
1. Mobilization and control of 3 cm of the runoff 
artery with its dominant venous concomitant. 
2. Arteriotomy and venotomy (2.5 cm) are 
placed at 10 o'clock and 2 o'clock correspond- 
ing positions (Fig. 2, A and C). 
3. Side-to-side posterior wall anastomosis of ar- 
tery to vein with 7-0 polypropylene; anasto- 
Fig. 2. Current method for performing common ostäum 
dAVF. Arteriotomy and venotomy are established at10 and 
2 o'clock (A and C). Side-to-sidc anastomosis is begun at 
midpoint of"posterior" wall (B). 
mosis is initiatcd at the midpoint level of the 
arterial and venous "otomies" (Fig. 2, B). 
4. Anastomosis  complcted by bringing the 7-0 
suture fore and alt to terminate at the artery- 
vein juncmre proximally and distally; the su- 
ture is not carried anteriorly as previously 
advocated (Fig. 3). 
5. Proximal and distal sutures arc tcrminated by 
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Fig. 3. dAVF suture line terminates at cephalad and 
caudad ends of parallel "otomies." 
A '! ,~ 
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Fig. 4. Small incisions (nicks) in each quadrant convert 
common osfium into rectangular shape, helping to avoid 
twisting of subsequent graft anastomosis. Interrupted su- 
tures (2 or 3) in each quadrant avoid stenosing anastomosis 
and fistula. 
Table I. Operative procedures using adjunctive dAVF (Jan. 1, 1979 to May 28, 1995) 
Procedure No. dAVF Configuration Conduit 
Femorocrural bypass 283 CO: 277 UV: 270 
PVP: 3 AV: l l  
DVP: 1 PTI~E: 2 
DVI: 2 
Femoroplantar bypass 3 CO: 3 Comp: 3 
Femoropopliteal bypass 3 RSS: 3 UV: 3 
Thrombectomy 1 RSS: 1 NA: 1 (SFA/Pop) 
Totals 290 CO: 280 UV: 273 
PVP: 3 AV: 11 
DVI': 1 PTFE: 2 
DVI: 2 Comp: 3 
IlùSS: 4 NA: 1 
CO, Common ostium; PVP, proximal vein piggyback; DVP, distal vein piggyback; DVI, deep vein interposition; RSS, remote side-to-side; 
UV, umbilical rein; AV, autotogous vein; NA, native artery; Comp, composite graft. 
6. 
7. 
tying to a single interrupted suture at each end 
(Fig. 3, A). 
Four separate "nicks" in each quadrant o 
convert the ovoid ostium to approximate a 
rectangular shape (Fig. 4, A). 
The bypass graft is anastomosed onto the 
common ostium dAVF by placing two or three 
interrupted 7-0 sutures in each quadrant, first 
proximally and then distally (Fig. 4, B); after 
tying down the graft proximally the sutures are 
run distally in a continuous manner to the 
midpoint. The distal toe is similarly sutured 
and tied into place with interrupted 7-0 
polypropylene sutures. These are run proxi- 
mally to meet and be tied to the corresponding 
sutures placed from above. 
8. Release of clamps (or thigh tourniquet) to 
permit retrograde flow and then infusion of 
heparin solution distally via graft before per- 
forming the proximal anastomosis. Graft is 
then tunneled cephalad to complete the proxi- 
mal anastomosis. 
9. After terminating all anastomoses, intraopera- 
tive angiography and duplex sonography are 
performed. We consider these monitoring 
methods a routine component of the opera- 
tion. The angiogram can be performed se- 
lectively before initiating the proximal anasto- 
mosis. 
When autologous vein is unavailable, unsuitable, 
or inappropriate, our graft material of choice is the 
glutaraldehyde-stabilized human umbilical rein 
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Fig. 5. Life-table patency rates for femoral crural pros- 
theUc grafts (predominantly umbilieal rein) with dAVF. 
Steady improvement is noted over the three time periods, 
with statistical significance established for the 1990 to 1995 
experience compared with the previous two series 
(p< 0.0001 for 1979-83 vs 1990-95; p=0.0007 for 
1984-89 vs 1990-95). 
graftfi '6 (Bio-Vascular, Inc., St. Paul, Minn.). We 
recently documented our experience with this mate- 
rial over the past two decades and demonstrated its
highly satisfactory performance when compared with 
other alternative conduits. 7 
All patients were followed clinically at 3- to 
4-month intervals during the first year and underwent 
noninvasive investigations in our vascular laboratory 
that included ankle-brachial or foot-brachial indexes 
and duplex sonography. Patency and limb salvage 
results were calculated with the Kaplan-Meier life 
table method. Statistical compailsons of these results 
were performed with Gehan's generalized Wilcoxon 
test (Breslow test). 8
RESULTS 
A steady trend ofimproving results, evidenced by 
both graft patency and limb salvage rates, is depicted 
in Tables II through VII. Cumulative secondary graft 
patency rates for the current seiles (1990 to 1995) at 
1,2, and 3 years were 77%, 69%, and 61%, respectively. 
Corresponding limb salvage rates were 81%, 79%, and 
75%. These figures compare favorably with our earlier 
experience and are depicted graphically in Figs. 5 and 
6. There were statistically significant differences for 
graft patency and limb salvage results obtained in the 
current seiles compared with those of the two previ- 
ous series (1979 to 1983 and 1984 to 1989). No 
statistically significant differences were found be- 
tween secondary, primary, or assisted primary patency 
rates. 
By performing routine surveillance studies with 
duplex sonography, fistula closure could be ascer- 
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Fig. 6. Life-table limb salvage rates for femoral crural 
prosthetic grafts (predominantly UV) with dAVF. Steady 
improvement is noted over the three time periods, with 
statistical significance established for the 1990-95 experi- 
ence compared with the two previous eries (p = 0.0016 for 
i979-83 vs 1990-95;p = 0.0082 for 1984-89 vs 1990-95). 
tained as graft patency was maintained. Accordingly, 
at 1, 2, and 3 years, fistula patency rates were 74%, 
61%, and 43%, respectively (Table VlII). From an 
alternative perspective, the first-year fistula closure 
rate of 26% decreased to annual attrition rates of 13% 
and 18% during the subsequent 2 years (Fig. 7). By 
supeilmposing the graft and fistula patency results, we 
note that only 3% of patent grafts were functional 
without a fistula after the first year, 8% by the end of 
the second year, and 18% after the third year. Mean- 
ingful differences beyond this time are negated by the 
paucity of grafts and fistulas for analysis, as evidenced 
by the elevated standard error values. M1 duplex 
examinations (intraoperative and postoperative sur- 
veillance) confirmed antegrade flow in the runoff 
artery beyond the fistula (Fig. 8). 
The perioperative mortality rate (<30 days) was 
1.4% (one patient), which represents improved case 
selection and the use of perioperative critical care 
monitoring, compared with previous rates that docu- 
mented amortality rate of 5% in tibial reconstructions 
and 7% for peroneal reconstructions, s The single 
death in the current seiles was caused by myocardial 
infarction with pulmonary edema on the second day 
after surgery. 
Other complications noted in this current series 
are shown in Table IX. M1 four infected grafts 
occurred in patients who had at least one previous 
operation. One patient had two operations, and two 
patients had undergone additional interventional 
proccdures in attempting to reopen the first bypass, 
Stenosis occurred in one patient at the distal anasto- 
mosis and in another at the proximal anastomosis, 
The distal stcnosis was successfully managed by bal- 
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Table I I .  Life table patency rates for femoral crural prosthetic grafts with dAVF--1979/83 
No. of Number wißdrawn patent 
grafts No. of Interval Interval 
Interval at risk failed Lost to failure patency 
(mo.) at start grafts Death follow -up Duration rate rate 
Cumulative 
patency rate SE 
0-1 111 18 2 0 0 .164 .836 .836 .035 
2-12 91 41 3 3 0 .466 .534 .447 .048 
13-24 44 23 1 6 0 .568 .432 .193 .041, 
25-36 14 4 1 9 0 .444 ,556 .107 .039 
Table I I I .  Life table patency rates for femoral crural prosthetic grafts with dAVF--1984-89 
No. of Number withdrawn patent 
grafts No. of Interval Interval 
Interval at risk failed Lost to failure patency 
(mo.) at start grafts Death follow-up Duration rate rate 
CumußHve 
pa~n~ra~ SE 
0-1 105 22 1 0 0 .211 .789 .790 .040 
2-12 82 18 6 2 0 .231 .769 .607 .049 
13-24 56 24 4 3 4 .475 .525 .319 .050 
25-36 21 3 1 7 10 .250 .750 .239 .055 
Table IV. Life table patency rates for femoral crural prosthetic grafts with dAVF--1990-95 
No. of Number withdrawn patent 
grafts No. of Interval Interval 
Interval at risk failed Lost to failure patency Cumulative 
(mo.) at start grafts Death follow-uß Duration rate rate patency rate SE 
0-1 71 10 1 0 0 .142 .858 .858 .042 
2-12 60 6 2 0 7 .108 .892 .765 .052 
13-24 45 4 8 1 5 .105 .895 .685 .060 
25-36 27 2 1 1 14 .105 .895 .613 .072 
37-48 9 0 0 2 3 0 1.0 .613 .072 
49-60 4 0 0 0 4 0 1.0 .613 .072 
loòn angioplasty. The proximal stenosis was managed 
by open patch angioplasty, but the graft closed 8 
months latcr. The total number ofamputations in this 
seiles (15) reflects the advanced stage of atheroscle- 
rosis, which is particularly evident in the peroneal 
group, where more than half of  the amputations were 
performed. 
DISCUSSION 
Adjunctive procedures to enhance prostheuc graft 
patcncy include anticoagulation, vein patches and 
cuffs, and creation of dAVFs. Anticoagulation was 
initially shown to be effective in enhancing polytet- 
rafluoroethylene patency in the popliteal position. 9
Although it is used on a widespread basis for virtually 
all prosthetic bypasses in the legs, concrete vidence 
for its efficacy for all types ofprosthetics, as weil as for 
its use with the other adjuncts, is lacking. 
In 1979 Siegman 1° first described the use ofa vein 
cuff that would permit a gradual transition of  flow 
dynamics between graft and artery. The Miller collar 
was developed in 198411 and, like the Siegman cuff, is 
formed from a segment of vein sutured to the 
circumference of the arteriotomy, but differs from it 
in that the graft is sutured at a 45 degree angle to the 
cuff. Because ofthis, there is a slightly wider opening 
at the anastomosis, and blood flow is enhanced 
through the graft. The Taylor patch 12 uses a different 
concept and is constructed by first making a short 
U-shaped slit in the toe segment of the graft and then 
suturing the heel of the graft to the cephalad end of 
the arteriotomy. An ellipse-shaped vein patch is then 
sutured to the graft and onto the distally extended 
arteilotomy. Tyrrell and Wolf 13 incorporated the 
advantages of both the collar and the patch by 
creating aboot-shaped venous reservoir to which the 
prosthetic graft is anastomosed. These methods focus 
on the vein as a compliance nhancer and anastomotic 
facilitator, leading to the possibility of improved early 
patency translafing into bettet mid- and long-term 
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Table V. Life table limb salvage rates for femoral crural prosthetic graffs with dAVF--1979-83 
No. of Number withdrawn patent 
grafts No. of Interval Interval 
Inter~al at risk failed Lost to failure patency Cumulative 
(mo.) at start grafts Death follow-up Duration rate rate patency rate SE 
0-1 111 12 2 0 0 .109 .891 .891 .030 
2-12 97 20 3 3 0 .213 .787 .701 .044 
13-24 71 21 1 6 0 .311 .689 .483 .050 
25-36 43 2 1 9 3 .089 .911 .440 .054 
Table VI. Life table limb salvage rates for femoral crural prosthetic grafts with dAVF--1984-89 
No. of Number withdrawn patent 
gratis No. of Interval Interval 
Interval at risk failed Lost to failure patency Cumulative 
(mo.) at start grafts Death follow-up Duration rate rate patency rate SE 
0-1 105 8 1 0 0 .077 .923 .923 .026 
2-12 96 19 6 2 0 .207 .793 .733 .044 
13-24 69 20 4 3 4 .315 .685 .502 .052 
25-36 38 1 1 7 29 .051 .949 .476 .056 
Table VI I .  Life table limb salvage rates for femoral crural prosthetic grafts with dAVF--1990-95 
No. of Number withdrawn patent Interval Cumulative 
limbs Interval limb limb 
Interval at risk No. of Lost to amputation salvage salvage 
(mo.) at start amputations Death follow-up Duration rate rate rate SE 
0-1 71 4 1 0 0 .057 .943 .943 .028 
2-12 66 9 2 0 7 .146 .854 .805 .049 
13-24 48 1 8 1 5 .024 .976 .786 .051 
25-36 33 1 1 1 16 .042 .958 .753 .059 
37-48 14 0 0 2 4 0 1.000 .753 .059 
49-60 8 0 0 0 8 0 1.000 .753 .059 
patency. Although compliance and hemodynamic 
advantages have been cited for these methods, 14-16 
convincing data based on prospective randomized 
studies are not available. Therefore, these issues and 
those that relate to fixed runoff resistance and mito- 
gen stimulation, release, and activity need to bc 
defined by laboratory and clinical investigations. 
The modern clinical era for creating distal fistulas 
began in 1979, when the senior author (HD) first 
used a concomitant vein for decompression of a 
peroneal bypass graft that was thrombosing repeti- 
tively during surgery. That fistula was constructed to 
the side of the distal graft using the cephalad vein 
segment with ligation of the caudad segment. Graft 
patency and lirnb salvage were maintained in that 
particular case until the patient's death from a stroke 
4 years later. On the basis of our experience using 
distal fistulas with prosthetic reconstructions to the 
crural arteries over the past 16 years, we have con- 
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Fig. 7. Life-table offistula patency depicts annual attrifion 
rates. 
cluded that these procedures are worthwhile and 
result both in decreased perioperafive thrombosis and 
in improvcd graft patency and limb salvage rates. 
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Fig. 8. Duplcx sonograms of femoral peroneal bypass with umbilical vcin graft, dAVF was 
performcd by common ostium method. Lom¢r pc~n¢l depicts antegradc flow in distal artcry, 
confirming abscncc of stcal. 
Placing the fismla proximal or remote to the distal 
anastomosis, originally proposcd by Harris et al. 2 and 
Paty et al.,3 respcctively, was considered as a means to 
obviate or lessen the possibility for steal to occur. In 
fact, the theoretic possibility for steal to occur is 
cnhanced by the "distal" method because reverse 
flow can be precipitated by the vascular channcls 
between the distal anastomosis and the downstream 
fistula. In practice, this method has not proved to be 
particularly advantageous. Similarly, no evidence sup- 
ports the continued placement ofa fistula proximal to 
the distal anastomosis. 
Also, no data support 0r refute the superiority of 
a particular configuration of an arteriovenous fi tula, 
but differenccs probably do cxist. Maurer et al. 17 
showed in transparent models that the 2-cm common 
ostium fistula was advantageous compared with 
smaller fistulas by exhibiting smooth flow patterns 
and improved hemodynamic parameters. Gcometric 
patterns and angulation affect shear and flow separa- 
tion, and as such will impact on compliance, fibrino- 
gen deposition, ccllular adhcsion, and other interfa- 
cial phcnomena that affcct he dcvelopmcnt ofintimal 
hyperplasia. Nonetheless, clear evidence for the vcin 
component of the distal anastomosis being directly 
rcsponsiblc for improved results does not exist. 
Sidawy et al. 18'19 suggested that improved patency 
ratcs associatcd with rein cuffs may be primarily 
chemical in origin by effccting thc release of active 
cellular molecules. 
Ascer et al. 4'2° have evaluatcd several variations on 
thc theme in which the venous system is used to 
provide egress for graft blood flow in addition to the 
known arterial runoff. Earlier models consisted of 
superficial veins (saphenous) being anastomosed to
the recipient artcry and then anastomosing the graft 
to this complcx. They have now rcfined thcir model as 
a fistula combined with deep vein interposition. The 
procedurc is pcrformed by anastomosing the ceph- 
alad portion of the ligated vena concomitant to the 
runoffartcry and then piggybacldng the graft on top 
of thc rein. The authors believc that the interposcd 
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Table VI I I .  Life table fistula patency rates for femoral crural prosthetic grafts with dAVF--1990-95 
No. of Number withdrawn patent 
fistulas Interval Interval Cumulative 
Interval at risk No. of Lost to failure patency patency 
(mo.) at start amputations Death follow-up Duration rate rate rate SE 
0-1 71 10 1 0 0 .142 .856 .858 .042 
2-12 60 8 2 0 7 .144 .856 .735 .054 
13-24 43 ö 8 1 5 .167 .833 .612 .064 
25-36 23 5 0 0 13 .303 .697 .427 .082 
37-48 5 1 0 2 1 .286 .714 .305 ..119 
49-60 1 0 0 0 1 0 I.O00 .305 .119 
Table IX. Complications offemoral crural dAVF cases (1990-1995) 
Group No. Infection (%) Stenosis (%) Amputation (%) 
Anterior tibial 10 0 1 3 
Posterior tibial 25 2 0 4 
Pcroncal 36 2 1 8 
Total 71 4 (5.6) 2 (2.8) 15 (21.1) 
vein acts not only as a fistula for venous decompres- 
sion but also serves as a vein cuff for improved 
compliancc and perhaps other mechanisms to im- 
prove graft patency. 
The most intfiguing aspect of the arteriovenous 
fistula concept rclates to the issue of stcaling. In 
general, steal cannot occur without an alternative 
arterial inflow. In the current series, completion and 
surveillance sonography confirmed the absence of 
steal by demonstration fcontinued prograde flow in 
the face offunctional fistulas. Reverse flowin the distal 
circulation was never noted. Ascer et al. 2° banded the 
venous outflow in almost one half of their patients to 
maintain distal perfusion pressure. This is startling in 
comparison with our series, where banding was per- 
formed in only two instanccs (2 of 290) in the original 
1979 to 1983 seiles (duplex was unavailable at that 
timc). This discrepancy raises the question as to 
whethcr the configuration of the fistula is the cause of 
the steal or whether it could possibly be on an 
altogethcr different basis. Jacobs et al.21 have eren 
gone so far as to suggest that the cephalad vein 
component of the fistula be routinely ligated to 
prcvcnt stealing, a concept hat, in our view, signifi- 
cantly negates the potential benefit of these fistulas. 
We speculate that the steal phenomenon observed by 
Ascer et al.20 is based on their usc ofpolytctrafluoro- 
ethylene, which, being incompliant, is restricted with 
the mount of blood flow that is possible through it, 
particularly with a large venous rcturn. The situation 
is analogous to an inflow stenosis proximal to a 
crossover graft, which then causes donor limb is- 
chemia. With our 0wn prefcrence for the umbilical 
vein graft as the conduit of choice in the absence of 
saphenous vein, we have been able to show increased 
volumetric flow rates well in excess of  400 ml per 
minute, a volume that can obviate the steal effect. In 
two recent cases, one with the common ostium 
method and the other by Ascer's interposiüon vein 
method, we found no gradient between distal intra- 
graft pressure and radial artery pressure. The real 
differences between thc Englewood and Maimonides 
series relates to the issue ofsteal, and this we believe 
relates to the unique differences in the graft materials 
we use and not the configurätion. 
The common ostium method and the interposi- 
tion vein model appear to be comparable in their ac- 
tivity and function, but randomized prospecüve stud- 
ies are necessary to demonstrate he superiority ofone 
or the other ifsuch exists. It is doubtful that this deter- 
mination can be successfully accomplished, soit may 
be appropriate to consider each of these fistulas to be 
performed on the basis of local anatomy and other 
technical factors. Technical skill is critical to the suc- 
cessful performance ofany type ofdistal arteriovenous 
fistula. In the case of the common ostium method, we 
advocate precise attention to (1) location of the arte- 
riotomy and venotomy and (2) prevcntion of stric- 
tures, stenosis, and twisting by precise suture tech- 
nique as weil as four quadrant "nicking" to convert an 
ovoid common ostium to a more rectangular shape. 
We conclude that graft and distal circulatory flow can 
be maintained with various type offistulas in the clini- 
cal setting, that graft patency and limb salvage rates 
are enhanced, and that more studies are required to 
understand the hemodynamics of the fistula and the 
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runoff circulation including the venous component. 
The vascular surgeon's perspectivc of the dAVF re- 
quires a transition from skepticism to critical analysis. 
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